Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

6.23
Delayed Data
As of Oct 20
 -0.02 / -0.32%
Today’s Change
5.28
Today|||52-Week Range
9.86
-10.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues12.5M8.5M10.4M20.4M
 
 
 
 
 
Depreciation And Amortization877.8K824.3K928.6K902.6K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses31.9M30.1M31.4M29.1M
 
 
 
 
 
Research And Development27.0M23.9M24.5M23.9M
 
 
 
 
 
Total Operating Expenses32.7M30.9M32.3M30.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.2M-22.4M-21.9M-9.6M
 
 
 
 
 
Extraordinary Credit2.7K--116.5K0.00
 
 
 
Extraordinary Charge0.00-4.1M0.00-312.5K
 
 
 
Other Expenses-566.5K191.5K-1.3M469.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.8M-26.2M-23.1M-9.5M
 
 
 
 
 
Net Income-20.8M-26.2M-23.1M-9.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS73.6M74.1M74.2M75.4M
 
 
 
 
 
Shares To Calculate EPS Diluted73.8M74.1M74.3M75.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.28-$0.36-$0.31-$0.13
 
 
 
 
 
EPS Diluted-$0.28-$0.35-$0.31-$0.13